[merz]

Ich bin mir nicht sicher, ob man sagen kann bei 5% wirkt er nicht, es gab in der Studie eine um 95% verringerte Anzahl an festgestellte Erkrankungen - was ich einfach spekatulär finde.
Und in der Verum Gruppe nur ein schweren Fall.

Auswertung Studie Biontech/Pfizer:

"A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days after the second dose among participants assigned to receive BNT162b2 and 162 cases among those assigned to placebo; BNT162b2 was 95% effective in preventing Covid-19 (95% credible interval, 90.3 to 97.6). Similar vaccine efficacy (generally 90 to 100%) was observed across subgroups defined by age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions. Among 10 cases of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1 in a BNT162b2 recipient. "

https://www.nejm.org/doi/full/10.105...34577?query=RP
Hervorgebung hinzugefügt.

Die Pressevorabmeldungen der Auswertung aus Israel scheinen in die gleiche Richtung zu deuten.


m.